Identifying TMEM127-deficient pheochromocytomas/paragangliomas via RET overexpression by immunohistochemistry

preprint OA: closed CC-BY-4.0
AI-generated deep summary by claude@2026-07, 2026-07-03 · read from full text

This preprint studied whether RET immunohistochemistry (IHC) can identify TMEM127 loss-of-function in pheochromocytomas/paragangliomas (PPGLs), focusing on patients with TMEM127 variants of uncertain significance (VUS) where functional interpretation is limited. Using histologic RET membrane and cytoplasmic staining scoring on 104 formalin-fixed, paraffin-embedded PPGL tumor sections spanning clinically and genetically diverse backgrounds, the authors found that tumors driven by TMEM127 variants had the highest RET expression scores, predominantly on the membrane, compared with RET pathogenic disruptions and undefined-genotype tumors. They also report that membrane immunoreactivity distinguished likely damaging TMEM127 variants from non-disrupting ones. A major caveat is that RET IHC’s utility for VUS interpretation requires validation in independent cohorts, and the work is a preprint that has not been peer reviewed. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Pheochromocytomas and paragangliomas (PPGLs) are rare, genetically diverse tumors originating from the adrenal medulla or extra-adrenal paraganglia, respectively. Defining a pathogenic variant is critical for patient management and family surveillance, particularly for the 35–40% of patients carrying a germline variant, including those in the TMEM127 gene. However, determining the functional impact of some variants remains challenging and requires additional testing. We recently reported that loss of TMEM127 promotes RET accumulation by reducing its degradation. Here, we evaluated RET expression by immunohistochemistry (IHC) as a potential aid to highlight TMEM127 dysfunction in PPGLs. We performed RET IHC in 104 formalin-fixed and paraffin-embedded (FFPE) sections of clinically and genetically diverse PPGLs and applied histochemical scoring (HS) for membrane (MH-S) and cytoplasm (CH-S) staining. Tumors driven by TMEM127 variants carried the highest RET expression scores (151.8 ± 62), predominantly MH-S, when compared with other PPGL genotypes, including those with RET pathogenic disruptions (69.9 ± 96.8, adjusted p = 0.04) or tumors of undefined genotype (40.8 ± 69, adjusted p = 0.0003), reflecting high specificity (100%) and sensitivity (91%). RET membrane immunoreactivity also distinguished PPGLs carrying non-disrupting TMEM127 variants from variants of uncertain significance (VUS) with likely damaging effects. These results point to high RET membrane expression as a biomarker for pathogenic TMEM127 and suggest that RET IHC may also assist in interpreting the functional impact of PPGLs carrying TMEM127 VUS.
Full text 18,227 characters · extracted from preprint-html · click to expand
Identifying TMEM127-deficient pheochromocytomas/paragangliomas via RET overexpression by immunohistochemistry | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Identifying TMEM127-deficient pheochromocytomas/paragangliomas via RET overexpression by immunohistochemistry Cynthia Estrada-Zuniga, Rui Liang, Bethany Landry, Andrea Alvarez, and 15 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-8553860/v2 This work is licensed under a CC BY 4.0 License Status: Posted Version 2 posted You are reading this latest preprint version Show more versions Abstract Context : Pheochromocytomas and paragangliomas (PPGLs) are rare, genetically diverse tumors originating from the adrenal medulla or extra-adrenal paraganglia, respectively. It is critically important to establish the pathogenic status of genetic variants, especially for the 35-40% patients carrying a germline change, as it impacts patient management and family surveillance. However, determining the clinical impact of variants of uncertain significance (VUS) remains challenging and requires additional testing. This is especially relevant for genes for which limited functional information is available, such as the TMEM127 gene. We recently reported that loss of TMEM127 promotes RET accumulation by reducing its degradation. Objective : Here, we evaluated RET expression by immunohistochemistry (IHC) as a potential aid to highlight TMEM127 dysfunction in PPGLs carrying TMEM127 germline variants. Methods : We performed RET IHC in 104 formalin-fixed and paraffin-embedded (FFPE) sections of clinically and genetically diverse PPGLs and applied histochemical scoring (HS) for membrane (MH-S) and cytoplasm (CH-S) staining. Results : Tumors driven by TMEM127 variants carried the highest RET expression scores (151.8±62), predominantly MH-S, when compared with all other PPGL genotypes, including those with RET pathogenic disruptions (69.9±96.8, adjusted p=0.03) or tumors of undefined genotype (40.8±69, adjusted p=0.0001). RET membrane immunoreactivity also distinguished PPGLs carrying TMEM127 germline variants with likely damaging effects from non-disrupting variants. Conclusions : These findings point to increased RET membrane expression as a promising biomarker for loss-of-function TMEM127 variants in PPGLs. If validated in independent cohorts, RET IHC could be an effective tool for assessing the functional implications of PPGLs from patients carrying TMEM127 VUS. TMEM127 RET pheochromocytomas paragangliomas immunohistochemistry germline variant biomarker VUS Full Text Additional Declarations The authors declare no competing interests. Supplementary Files EstradaZunigasupplfigures.pdf Cite Share Download PDF Status: Posted Version 2 posted You are reading this latest preprint version Show more versions Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-8553860","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":577446757,"identity":"e8ebf953-9d82-41b0-8ca3-b67c32af0a13","order_by":0,"name":"Cynthia Estrada-Zuniga","email":"","orcid":"","institution":"The University of Texas Health Science Center at San Antonio","correspondingAuthor":false,"prefix":"","firstName":"Cynthia","middleName":"","lastName":"Estrada-Zuniga","suffix":""},{"id":577446758,"identity":"9e749cc9-457c-4ba6-a3ad-aa0a6feaf677","order_by":1,"name":"Rui Liang","email":"","orcid":"","institution":"The University of Texas Health Science Center at San Antonio","correspondingAuthor":false,"prefix":"","firstName":"Rui","middleName":"","lastName":"Liang","suffix":""},{"id":577446759,"identity":"e0c13e49-dc9a-49fe-bb3a-07839dc9622a","order_by":2,"name":"Bethany Landry","email":"","orcid":"","institution":"The University of Texas Health Science Center at San Antonio","correspondingAuthor":false,"prefix":"","firstName":"Bethany","middleName":"","lastName":"Landry","suffix":""},{"id":577446760,"identity":"66f3c37a-5b3b-4ba8-b218-d4f98a4a0b45","order_by":3,"name":"Andrea Alvarez","email":"","orcid":"","institution":"The University of Texas Health Science Center at San Antonio","correspondingAuthor":false,"prefix":"","firstName":"Andrea","middleName":"","lastName":"Alvarez","suffix":""},{"id":577446761,"identity":"53c4ae70-577b-4c24-b37b-6b040a0dd9af","order_by":4,"name":"Hector Gonzalez-Cantu","email":"","orcid":"","institution":"The University of Texas Health Science Center at San Antonio","correspondingAuthor":false,"prefix":"","firstName":"Hector","middleName":"","lastName":"Gonzalez-Cantu","suffix":""},{"id":577446762,"identity":"dd582b01-e0a1-4318-89ad-beac39792cd4","order_by":5,"name":"Viviane Nascimento da Conceicao","email":"","orcid":"","institution":"The University of Texas Health Science Center at San Antonio","correspondingAuthor":false,"prefix":"","firstName":"Viviane","middleName":"Nascimento da","lastName":"Conceicao","suffix":""},{"id":577446763,"identity":"3b07f385-8a96-4310-9fe8-f5d739a5f6c2","order_by":6,"name":"Rolando Trevino","email":"","orcid":"","institution":"The University of Texas Health Science Center at San Antonio","correspondingAuthor":false,"prefix":"","firstName":"Rolando","middleName":"","lastName":"Trevino","suffix":""},{"id":577446764,"identity":"5b6a3341-0055-4bda-9705-f124d7d15e5b","order_by":7,"name":"David Gius","email":"","orcid":"","institution":"The University of Texas Health Science Center at San Antonio","correspondingAuthor":false,"prefix":"","firstName":"David","middleName":"","lastName":"Gius","suffix":""},{"id":577446765,"identity":"7cac61ce-c5fa-4697-9718-f25250aaf4ca","order_by":8,"name":"Sylvia Asa","email":"","orcid":"","institution":"Case Western Reserve University","correspondingAuthor":false,"prefix":"","firstName":"Sylvia","middleName":"","lastName":"Asa","suffix":""},{"id":577446766,"identity":"9604192e-1787-440c-b957-36b49f5b484a","order_by":9,"name":"James Powers","email":"","orcid":"","institution":"Tufts Medical Center","correspondingAuthor":false,"prefix":"","firstName":"James","middleName":"","lastName":"Powers","suffix":""},{"id":577446767,"identity":"4e3e2d17-ef33-4146-b53e-1725ae1ac390","order_by":10,"name":"Tamara Prodanov","email":"","orcid":"","institution":"NICHHD","correspondingAuthor":false,"prefix":"","firstName":"Tamara","middleName":"","lastName":"Prodanov","suffix":""},{"id":577446768,"identity":"04ae6b6e-e49f-4b86-aaca-3ecd8190439e","order_by":11,"name":"Anand Vaidya","email":"","orcid":"","institution":"Brigham and Women's Hospital","correspondingAuthor":false,"prefix":"","firstName":"Anand","middleName":"","lastName":"Vaidya","suffix":""},{"id":577446769,"identity":"a30c41fd-a0a0-47d6-9472-1fcae5536473","order_by":12,"name":"Rodrigo Toledo","email":"","orcid":"","institution":"Vall d'Hebron Hospital Universitari","correspondingAuthor":false,"prefix":"","firstName":"Rodrigo","middleName":"","lastName":"Toledo","suffix":""},{"id":577446770,"identity":"0c461829-2c00-49b0-a28d-8b5721ae1586","order_by":13,"name":"Jean Pierre Bayley","email":"","orcid":"","institution":"Leiden University","correspondingAuthor":false,"prefix":"","firstName":"Jean","middleName":"Pierre","lastName":"Bayley","suffix":""},{"id":577446771,"identity":"95d14745-2f2a-468e-9959-5002109288b1","order_by":14,"name":"Debbie Cohen","email":"","orcid":"","institution":"University of Pennsylvania","correspondingAuthor":false,"prefix":"","firstName":"Debbie","middleName":"","lastName":"Cohen","suffix":""},{"id":577446772,"identity":"f675eab1-a64d-420f-9f8c-8e30e2542c39","order_by":15,"name":"Arthur Tischler","email":"","orcid":"","institution":"Tufts Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Arthur","middleName":"","lastName":"Tischler","suffix":""},{"id":577446773,"identity":"f7077ef1-68ea-48d9-b3f2-03607826ab3d","order_by":16,"name":"Karel Pacak","email":"","orcid":"","institution":"Center for Adrenal Tumors, AKESO","correspondingAuthor":false,"prefix":"","firstName":"Karel","middleName":"","lastName":"Pacak","suffix":""},{"id":577446774,"identity":"4320bdef-5853-43ae-981f-55d5c44f272e","order_by":17,"name":"Faqian Li","email":"","orcid":"","institution":"The University of Texas Health Science Center at San Antonio","correspondingAuthor":false,"prefix":"","firstName":"Faqian","middleName":"","lastName":"Li","suffix":""},{"id":577446775,"identity":"79065885-692c-4a6d-8a93-18e52be6a9b5","order_by":18,"name":"Patricia Dahia","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAAyUlEQVRIiWNgGAWjYDCCAzwMBxgqGBgMoHzGBuK0nGGQIE0LA2MbKVr4jp89eODnvMN15vyHH3/4wWAju+EAAS2SZ/ISDvZuOyxhOSPNTLKHIc2YoBaDAzkGB3iBWgxu8LAx8DAcTiSs5fwbg4N/5wC1nD/D/PEPw38itNzIMTjM2wDUciCHQRoYeoS1SN54Y3BY5li65IYbaWbSMgbJxjMJaeE7n2P88U2NNb/B+cOPP76psJPtI6QF3Z2kKR8Fo2AUjIJRgAMAALltSzjJN/qsAAAAAElFTkSuQmCC","orcid":"","institution":"The University of Texas Health Science Center at San Antonio","correspondingAuthor":true,"prefix":"","firstName":"Patricia","middleName":"","lastName":"Dahia","suffix":""}],"badges":[],"createdAt":"2026-01-08 16:53:44","currentVersionCode":2,"declarations":{"humanSubjects":false,"vertebrateSubjects":false,"conflictsOfInterestStatement":false,"humanSubjectEthicalGuidelines":false,"humanSubjectConsent":false,"humanSubjectClinicalTrial":false,"humanSubjectCaseReport":false,"vertebrateSubjectEthicalGuidelines":false},"doi":"10.21203/rs.3.rs-8553860/v2","doiUrl":"https://doi.org/10.21203/rs.3.rs-8553860/v2","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":103050570,"identity":"afb1540a-0ee8-4075-86eb-11e60e6f9487","added_by":"auto","created_at":"2026-02-20 07:50:36","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1307628,"visible":true,"origin":"","legend":"","description":"","filename":"EstradaZunigaetal02122026.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8553860/v2_covered_db668bf9-50ab-45d6-98c3-c0ea40fac189.pdf"},{"id":103029677,"identity":"9d71b486-c888-48c2-9f60-917330be5d5f","added_by":"auto","created_at":"2026-02-19 21:45:43","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"supplement","size":3383594,"visible":true,"origin":"","legend":"","description":"","filename":"EstradaZunigasupplfigures.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8553860/v2/898778c905d4737451e90206.pdf"}],"financialInterests":"The authors declare no competing interests.","formattedTitle":"Identifying TMEM127-deficient pheochromocytomas/paragangliomas via RET overexpression by immunohistochemistry","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"TMEM127, RET, pheochromocytomas, paragangliomas, immunohistochemistry, germline variant, biomarker, VUS","lastPublishedDoi":"10.21203/rs.3.rs-8553860/v2","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-8553860/v2","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cstrong\u003eContext\u003c/strong\u003e: Pheochromocytomas and paragangliomas (PPGLs) are rare, genetically diverse tumors originating from the adrenal medulla or extra-adrenal paraganglia, respectively. It is critically important to establish the pathogenic status of genetic variants, especially for the 35-40% patients carrying a germline change, as it impacts patient management and family surveillance. However, determining the clinical impact of variants of uncertain significance (VUS) remains challenging and requires additional testing. This is especially relevant for genes for which limited functional information is available, such as the \u003cem\u003eTMEM127\u003c/em\u003e gene. We recently reported that loss of \u003cem\u003eTMEM127\u003c/em\u003e promotes RET accumulation by reducing its degradation.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eObjective\u003c/strong\u003e: Here, we evaluated RET expression by immunohistochemistry (IHC) as a potential aid to highlight TMEM127 dysfunction in PPGLs carrying \u003cem\u003eTMEM127\u003c/em\u003e germline variants.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMethods\u003c/strong\u003e: We performed RET IHC in 104 formalin-fixed and paraffin-embedded (FFPE) sections of clinically and genetically diverse PPGLs and applied histochemical scoring (HS) for membrane (MH-S) and cytoplasm (CH-S) staining.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eResults\u003c/strong\u003e: Tumors driven by \u003cem\u003eTMEM127\u003c/em\u003evariants carried the highest RET expression scores (151.8±62), predominantly MH-S, when compared with all other PPGL genotypes, including those with \u003cem\u003eRET \u003c/em\u003epathogenic disruptions (69.9±96.8, adjusted p=0.03) or tumors of undefined genotype (40.8±69, adjusted p=0.0001). RET membrane immunoreactivity also distinguished PPGLs carrying \u003cem\u003eTMEM127 \u003c/em\u003egermline variants with likely damaging effects from non-disrupting variants.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConclusions\u003c/strong\u003e: These findings point to increased RET membrane expression as a promising biomarker for loss-of-function \u003cem\u003eTMEM127\u003c/em\u003evariants in PPGLs. If validated in independent cohorts, RET IHC could be an effective tool for assessing the functional implications of PPGLs from patients carrying \u003cem\u003eTMEM127\u003c/em\u003e VUS.\u003c/p\u003e","manuscriptTitle":"Identifying TMEM127-deficient pheochromocytomas/paragangliomas via RET overexpression by immunohistochemistry","msid":"","msnumber":"","nonDraftVersions":[{"code":2,"date":"2026-02-19 21:45:10","doi":"10.21203/rs.3.rs-8553860/v2","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}},{"code":1,"date":"2026-01-20 12:22:54","doi":"10.21203/rs.3.rs-8553860/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"5c4731a8-66a1-4f20-8798-c86b2697a13a","owner":[],"postedDate":"February 19th, 2026","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[],"tags":[],"updatedAt":"2026-02-02T22:24:16+00:00","versionOfRecord":[],"versionCreatedAt":"2026-02-19 21:45:10","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v2","identity":"rs-8553860","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-8553860","identity":"rs-8553860","version":["v2"]},"buildId":"XKTyCvWXoU3ODBz1xrDgd","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-24T02:00:01.246996+00:00
License: CC-BY-4.0